Jacquelyn Terry
Psychiatric/Mental Health · Troy, MINPI 1245772292
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 334 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,603, 2.9 times the $913 reported in 2021. Among psychiatric/mental health clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 334 payments — averaging $24.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Teva Pharmaceuticals USA, Inc.$805
- Supernus Pharmaceuticals, Inc.$692
- Axsome Therapeutics, Inc.$650
- Corium, LLC$639
- plus $3K from 18 others
What the payments were for
- Food & beverage$8,245100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 46 | $1,109 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 33 | $1,057 |
| Teva Pharmaceuticals USA, Inc. | 21 | $805 |
| Supernus Pharmaceuticals, Inc. | 45 | $692 |
| Axsome Therapeutics, Inc. | 16 | $650 |
| Corium, LLC | 40 | $639 |
| Validus Pharmaceuticals LLC | 5 | $532 |
| Alkermes, Inc. | 9 | $359 |
| Collegium Pharmaceutical, Inc. | 27 | $344 |
| Lundbeck LLC | 19 | $302 |
| Otsuka America Pharmaceutical, Inc. | 11 | $301 |
| Noven Therapeutics, LLC | 15 | $271 |
| Idorsia Pharmaceuticals US Inc | 5 | $192 |
| Ironshore Pharmaceuticals Inc. | 11 | $185 |
| E.r. Squibb & Sons, L.L.C. | 2 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $135 |
| Noven Pharmaceuticals, Inc. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 4 | $103 |
| Sunovion Pharmaceuticals Inc. | 6 | $88 |
| Tris Pharma Inc | 4 | $76 |
| Neos Therapeutics, LP | 3 | $62 |
| Johnson & Johnson | 2 | $44 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Sage Therapeutics, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,245 in reported general payments places this provider in the 95th percentile of 638 psychiatric/mental health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 12 | $138 |
| Alprazolam | 14 | $30 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Troy
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
- Gladys KimeliSaginaw$17K
- Cynthia MaiSaginaw$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.